Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Gastroenterology and Hepatology|March 2, 2019
Human amnion epithelial cells and their soluble factors reduce liver fibrosis in murine non-alcoholic steatohepatitisNathan Kuk, Alexander Hodge, Ying Sun, et al.
Cell Transplantation|August 20, 2020
Human Amnion Epithelial Cells Produce Soluble Factors that Enhance Liver Repair by Reducing Fibrosis While Maintaining Regeneration in a Model of Chronic Liver InjuryAlexander Hodge, Neil Andrewartha, Dinushka Lourensz, et al.
Nutrients|November 25, 2023
Carnosine Did Not Affect Vascular and Metabolic Outcomes in Patients with Prediabetes and Type 2 Diabetes: A 14-Week Randomized Controlled TrialSaeede Saadati, James Cameron, Kirthi Menon, et al.
Plos One|June 22, 2012
Human amniotic epithelial cell transplantation induces markers of alternative macrophage activation and reduces established hepatic fibrosisUrsula Manuelpillai, Dinushka Lourensz, Vijesh Vaghjiani, et al.
Nutrients|December 9, 2023
Time-Restricted Fasting Improves Liver Steatosis in Non-Alcoholic Fatty Liver Disease-A Single Blinded Crossover TrialJack Feehan, Alexandra Mack, Caroline Tuck, et al.
Hepatology Communications|January 29, 2024
Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitisSven M Francque, Alexander Hodge, Jerome Boursier, et al.
Frontiers in Pharmacology|November 9, 2017
The Human Amnion Epithelial Cell Secretome Decreases Hepatic Fibrosis in Mice with Chronic Liver FibrosisMajid Alhomrani, Jeanne Correia, Marcus Zavou, et al.
Stem Cells Translational Medicine|April 15, 2024
Human Amniotic Epithelial Cell Transplantation is Safe and Well Tolerated in Patients with Compensated Cirrhosis: A First-in-Human TrialRebecca Lim, Alexander Hodge, Sherryne Warner, et al.
Hepatology (Baltimore, Md.)|July 16, 2008
Visceral fat: a key mediator of steatohepatitis in metabolic liver diseaseDavid van der Poorten, Kerry-Lee Milner, Jason Hui, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 12, 2023
Metabolic dysfunction-associated steatotic liver disease in older adults is associated with frailty and social disadvantageDaniel Clayton-Chubb, William W Kemp, Ammar Majeed, et al.
Pageof 3